newsfilter
← Latest News
GlobeNewswire·

Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022

- The event will feature Prometheus management and key opinion leader presentations on PR600 target unveiling, scientific rationale, and corresponding therapeutic candidate, PRA052 - - PRA052 is a novel, first-in-class monoclonal antibody ad